George Chiu

1.2k total citations
42 papers, 903 citations indexed

About

George Chiu is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Urology. According to data from OpenAlex, George Chiu has authored 42 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 16 papers in Radiation and 10 papers in Urology. Recurrent topics in George Chiu's work include Advanced Radiotherapy Techniques (16 papers), Urinary Bladder and Prostate Research (10 papers) and Hormonal and reproductive studies (8 papers). George Chiu is often cited by papers focused on Advanced Radiotherapy Techniques (16 papers), Urinary Bladder and Prostate Research (10 papers) and Hormonal and reproductive studies (8 papers). George Chiu collaborates with scholars based in United States, Hong Kong and United Kingdom. George Chiu's co-authors include Carlos Forray, Shengjian Li, Peter J. Connolly, Herbert Lepor, Paul Hartig, Rui Tang, Ellen Shapiro, Richard L. Weinshank, Jonathan Bard and T A Branchek and has published in prestigious journals such as Journal of Medicinal Chemistry, International Journal of Radiation Oncology*Biology*Physics and Biochemical Pharmacology.

In The Last Decade

George Chiu

37 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Chiu United States 12 377 273 208 175 123 42 903
Osamu Inagaki Japan 16 83 0.2× 326 1.2× 145 0.7× 165 0.9× 90 0.7× 74 834
Laurie Tota United States 17 339 0.9× 598 2.2× 43 0.2× 182 1.0× 133 1.1× 25 1.1k
Torsten Minuth Germany 14 90 0.2× 584 2.1× 35 0.2× 89 0.5× 58 0.5× 17 1.2k
N. Wesley Norton United States 9 101 0.3× 169 0.6× 152 0.7× 20 0.1× 52 0.4× 11 482
Thomas M. Argentieri United States 15 154 0.4× 422 1.5× 159 0.8× 29 0.2× 139 1.1× 34 800
Anthony H. Ingall United Kingdom 12 170 0.5× 240 0.9× 13 0.1× 27 0.2× 74 0.6× 14 789
Monica Einstein United States 10 88 0.2× 432 1.6× 14 0.1× 410 2.3× 35 0.3× 14 826
E. Schillinger Germany 18 163 0.4× 243 0.9× 12 0.1× 256 1.5× 46 0.4× 58 1.1k
Counde O-Yang United States 13 266 0.7× 311 1.1× 16 0.1× 14 0.1× 54 0.4× 22 649
Anne‐Charlotte Le Monnier de Gouville France 8 221 0.6× 349 1.3× 8 0.0× 44 0.3× 30 0.2× 9 642

Countries citing papers authored by George Chiu

Since Specialization
Citations

This map shows the geographic impact of George Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Chiu more than expected).

Fields of papers citing papers by George Chiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Chiu. The network helps show where George Chiu may publish in the future.

Co-authorship network of co-authors of George Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of George Chiu. A scholar is included among the top collaborators of George Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Chiu. George Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramalingam, Suresh S., Michael B. Thomas, Rachel E. Sanborn, et al.. (2025). OA05.04 A Randomized Phase 3 Study of Niraparib Plus Pembrolizumab as Maintenance Therapy for Advanced/Metastatic NSCLC: ZEAL-1L. Journal of Thoracic Oncology. 20(10). S20–S21. 1 indexed citations
2.
Poon, Darren M.C., Jing Yuan, Oi Lei Wong, et al.. (2025). Stereotactic total ablative radiotherapy with MR-LINAC for synchronous oligometastatic prostate cancer. Frontiers in Oncology. 15. 1607610–1607610.
3.
Poon, Darren M.C., Jing Yuan, Oi Lei Wong, et al.. (2024). One-year clinical outcomes of MR-guided stereotactic body radiation therapy with rectal spacer for patients with localized prostate cancer. World Journal of Urology. 42(1). 97–97. 3 indexed citations
4.
Wong, Oi Lei, Jing Yuan, Darren M.C. Poon, et al.. (2024). Prostate diffusion-weighted imaging (DWI) in MR-guided radiotherapy: Reproducibility assessment on 1.5 T MR-Linac and 1.5 T MR-simulator. Magnetic Resonance Imaging. 111. 47–56. 1 indexed citations
5.
Yang, Bin, Hui Geng, Chen‐Yu Huang, et al.. (2022). Clinical implementation of kVCT-guided tomotherapy with ClearRT. Physical and Engineering Sciences in Medicine. 45(3). 915–924. 2 indexed citations
6.
Chiu, George, et al.. (2017). Evaluation of deformed image-based dose calculations for adaptive radiotherapy of nasopharyngeal carcinoma. Medical dosimetry. 42(4). 273–281. 4 indexed citations
7.
Chiu, George, et al.. (2013). Can Planned Dose Shifting Method Be Used in Place of Dose Recalculation Method for Dose Evaluation in Adaptive Radiation Therapy of Head-and-Neck Cancer?. International Journal of Radiation Oncology*Biology*Physics. 87(2). S703–S704. 1 indexed citations
8.
Lee, Joseph W. Y., et al.. (2013). Evaluation of radiosurgery techniques–Cone-based linac radiosurgery vs tomotherapy-based radiosurgery. Medical dosimetry. 38(2). 184–189. 5 indexed citations
9.
Li, Shengjian, George Chiu, Virginia Pulito, et al.. (2009). Synthesis, In Vitro Activities of (2-Cyclopropoxyphenyl)piperidine Derivatives for α1a and α1d Adrenergic Receptor Inhibitors. Medicinal Chemistry. 5(1). 15–22. 3 indexed citations
10.
Chiu, George, Peter J. Connolly, Steven A. Middleton, et al.. (2008). α1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms. Expert Opinion on Therapeutic Patents. 18(12). 1351–1360. 5 indexed citations
11.
Chiu, George, Shengjian Li, Peter J. Connolly, et al.. (2007). Aminocyclohexylsulfonamides: Discovery of metabolically stable α1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS). Bioorganic & Medicinal Chemistry Letters. 17(22). 6123–6128. 5 indexed citations
12.
Chiu, George, Shengjian Li, Peter J. Connolly, et al.. (2007). (Phenylpiperazinyl)cyclohexylureas: Discovery of α1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS). Bioorganic & Medicinal Chemistry Letters. 18(2). 640–644. 9 indexed citations
13.
Li, Shengjian, George Chiu, Virginia Pulito, et al.. (2007). 1-Arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones as potent and selective α-1a/1d adrenergic receptor ligands. Bioorganic & Medicinal Chemistry Letters. 17(6). 1646–1650. 17 indexed citations
15.
Huang, Shenlin, Ronghui Lin, Yang Yu, et al.. (2006). Synthesis of 3-(1H-benzimidazol-2-yl)-5-isoquinolin-4-ylpyrazolo[1,2-b]pyridine, a potent cyclin dependent kinase 1 (CDK1) inhibitor. Bioorganic & Medicinal Chemistry Letters. 17(5). 1243–1245. 101 indexed citations
16.
Chiu, George, Charles Gluchowski, & Carlos Forray. (2006). Design and Synthesis of anα1a‐Adrenergic Receptor Subtype‐Selective Antagonist from BE2254. Chemical Biology & Drug Design. 67(6). 437–439. 4 indexed citations
17.
Lagu, Bharat, George Chiu, Dhanapalan Nagarathnam, et al.. (2000). Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective α1a-adrenergic receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 10(2). 175–178. 39 indexed citations
18.
Marzabadi, Mohammad R., Dhanapalan Nagarathnam, George Chiu, et al.. (1999). Design and synthesis of novel dihydropyridine alpha-1A antagonists. Bioorganic & Medicinal Chemistry Letters. 9(19). 2843–2848. 4 indexed citations
19.
Wong, Wai C., George Chiu, John M. Wetzel, et al.. (1998). Identification of a Dihydropyridine as a Potent α1a Adrenoceptor-Selective Antagonist That Inhibits Phenylephrine-Induced Contraction of the Human Prostate. Journal of Medicinal Chemistry. 41(14). 2643–2650. 24 indexed citations
20.
Forray, Carlos, Jonathan Bard, George Chiu, et al.. (1994). The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.. Molecular Pharmacology. 45(4). 703–708. 312 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026